Recipient Title Chief Executive Officer and Director, 10800 Roosevelt Blvd. N. St. Petersburg , FL 33716 United States, (b)(4)FEI 3006503102Issued Aug 27, 2026Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3006503102.
Violations4
Issue DateAug 27, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
Jabil Inc.
Location
Recipient Title Chief Executive Officer and Director, 10800 Roosevelt Blvd. N. St. Petersburg , FL 33716 United States, (b)(4)
Talk to a Specialist